Skip to content

NeuCyte vs PsychoGenics

NeuCyte logo

NeuCyte

Decoding CNS Drug Discovery with SynFire® iP

11 employees · est. 2015 · Mountain View, United States

VS
PsychoGenics logo

PsychoGenics

Discover Your Next Breakthrough

146 employees · est. 1999 · Paramus, United States

PsychoGenics is the older company (2015 vs 1999); PsychoGenics is the larger of the two.

Side-by-Side Comparison

NeuCyte PsychoGenics
Founded
2015 1999 older
Headquarters
Mountain View, United States Paramus, United States
Employees
11 146 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Series A Grant
Total Funding
$6.70M $522.00K
Funding Rounds
3 2
Services
Neural Cell Production, Assay Development, Functional Phenotypic Assessment, Custom iPSC-Derived Cell Production, Compound Screening Not tracked yet
Target Customers
Biopharmaceutical Companies, Neurological Research Institutes, Medical Researchers, Pharmaceutical Firms, Biotech Startups Focusing on Neurological Conditions Not tracked yet
Taxonomy
CNS Drug DiscoveryNeurological DisordersNeural Cell TechnologyStem Cell BiologyDrug DevelopmentHuman Neural Platform +8 CNS DisordersOrphan DisordersPreclinical CROTranslational ResearchDisease ModelsBehavioral Testing +9
Website
neucyte.com psychogenics.com
NeuCyte logo

About NeuCyte

NeuCyte, founded in 2015 and headquartered in the United States, is pioneering advancements in the biotechnology sector with a focus on central nervous system (CNS) drug discovery. Their slogan, "Decoding CNS Drug Discovery with SynFire® iP," encapsulates their mission of refining preclinical testin...

PsychoGenics logo

About PsychoGenics

PsychoGenics is a preclinical CRO specializing in CNS and orphan disorders, aiming to provide top-tier disease models and comprehensive preclinical capabilities for the discovery of advanced treatments and reduction of attrition rates in clinical development. The company is recognized for its cuttin...

Also comparing in this category

Comparing more than these two?

Get NeuCyte, PsychoGenics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does NeuCyte compare?

A PDF of NeuCyte and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

NeuCyte was founded in 2015, based in Mountain View, United States, with 11 employees. NeuCyte, founded in 2015 and headquartered in the United States, is pioneering advancements in the biotechnology sector with a focus on central nervous system (CNS) drug discovery. Their slogan, "Deco. PsychoGenics was founded in 1999, based in Paramus, United States, with 146 employees. PsychoGenics is a preclinical CRO specializing in CNS and orphan disorders, aiming to provide top-tier disease models and comprehensive preclinical capabilities for the discovery of advanced treatment.
NeuCyte has raised $6.70M and PsychoGenics $522.00K. Latest stage: NeuCyte Series A, PsychoGenics Grant.
Both work in Biotechnology and Health Care and list neurological disorders among their focus areas.

Compare NeuCyte with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at NeuCyte on 14 Sep 2024, and PsychoGenics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout